Frequent alterations of HER2 through mutation, amplification, or overexpression in pleomorphic lobular carcinoma of the breast

Breast Cancer Research and Treatment
Huang-Chun LienYung-Ming Jeng

Abstract

Mutations in HER2 gene have been identified in a small subset of breast cancer cases. Identification of HER2 mutation has therapeutic implications for breast cancer, but whether a subgroup of breast cancer with a higher frequency of HER2 mutation exists, remains unknown. We analyzed HER2 mutation and pathologic factors on 73 formalin-fixed, paraffin-embedded samples, including 21 pleomorphic invasive lobular carcinoma (p-ILC) cases, 3 pleomorphic lobular carcinoma in situ (p-LCIS) cases, and 49 classic invasive lobular carcinoma (c-ILC) cases. Mutations were identified through direct sequencing. HER2 overexpression and amplification were determined through immunohistochemistry and fluorescent in situ hybridization. Six mutations were identified, including five in the 24 p-ILC or p-LCIS (p-ILC/p-LCIS) cases (20.8 %) and one in the 49 c-ILC cases (2.0 %), and the difference in frequency was significant (p = 0.013). Eight of the 24 (33.3 %) p-ILC/p-LCIS cases exhibited HER2 amplification or overexpression (amplification/overexpression), which was significantly higher than in the c-ILC cases (1/49, 2 %). Mutation and amplification/overexpression were mutually exclusive. HER2 mutations were identified more frequently in the p-ILC/p-...Continue Reading

References

Oct 1, 1992·Human Pathology·N Weidner, J P Semple
May 1, 1989·Histopathology·N Walford, J ten Velden
Jul 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B FisherN V Dimitrov
Aug 30, 2000·Nature·C M PerouD Botstein
Mar 15, 2003·JAMA : the Journal of the American Medical Association·Christopher I LiRoger E Moe
Jun 28, 2003·Proceedings of the National Academy of Sciences of the United States of America·Therese SorlieDavid Botstein
Sep 3, 2004·Nature Reviews. Cancer·Nick J DibbClifford D Mol
Oct 1, 2004·Nature·Philip StephensMichael R Stratton
Jun 16, 2006·The New England Journal of Medicine·Federico CappuzzoMarileila Varella-Garcia
Nov 13, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Reshma L Mahtani, Charles L Vogel
Mar 17, 2009·Future Oncology·Ana-Cristina VargasPeter T Simpson
Nov 10, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Leo A NiemeierRohit Bhargava
Mar 15, 2011·Journal of Clinical Pathology·Puay Hoon TanGary Man-Kit Tse
Apr 11, 2012·Histopathology·Laketa MonhollenThaer Khoury
Aug 22, 2012·Proceedings of the National Academy of Sciences of the United States of America·Heidi GreulichMatthew Meyerson
Sep 25, 2012·Nature·UNKNOWN Cancer Genome Atlas Network
Oct 5, 2012·The Breast Journal·Jennifer E JohM Catherine Lee
Dec 12, 2012·Cancer Discovery·Ron BoseMatthew J Ellis
Apr 12, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jeffrey S RossPhilip J Stephens
Oct 9, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio C WolffUNKNOWN College of American Pathologists
Nov 7, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jeffrey S RossPhilip J Stephens
Feb 12, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Siraj M AliMassimo Cristofanilli

❮ Previous
Next ❯

Citations

Aug 11, 2015·Pharmacogenomics·Adela Madrid-ParedesMiguel Ángel Calleja-Hernández
May 4, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Adela Madrid-ParedesMiguel Ángel Calleja-Hernández
May 29, 2016·Pathology, Research and Practice·Matthias ChristgenHans Kreipe
Mar 24, 2010·Seminars in Diagnostic Pathology·Emad A Rakha, Ian O Ellis
Aug 16, 2016·The Breast : Official Journal of the European Society of Mastology·Michael J DuffyJohn Crown
Mar 2, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christine DesmedtChristos Sotiriou
Sep 8, 2016·Oncotarget·Gabrielle DeniziautAnne Vincent-Salomon
Jan 15, 2020·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Beth T HarrisonTari A King
Jan 21, 2017·Oncology Letters·Umar WazirKefah Mokbel
Aug 11, 2018·Virchows Archiv : an International Journal of Pathology·Matthias ChristgenHans Kreipe
Feb 23, 2018·Journal of the National Cancer Institute·Steffi OesterreichDario A A Vignali
Jan 15, 2021·Breast Cancer Research : BCR·Gregory M RiedlingerShridar Ganesan
Jan 9, 2021·Breast Cancer Research : BCR·Amy E McCart ReedSunil R Lakhani
Mar 1, 2021·The Oncologist·Nikhil PramodBhuvaneswari Ramaswamy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Carcinoma, Lobular

Lobular carcinoma is an invasive type of breast cancer in which lobules, areas of the breast that produce milk, undergo malignant transformation. Here is the latest research.